Besides Wall Street's top -and-bottom-line estimates for McKesson (MCK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) closed at $712.79 in the latest trading session, marking a +0.78% move from the prior day.
McKesson (MCK) reachead $699.73 at the closing of the latest trading day, reflecting a +0.68% change compared to its last close.
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In the latest trading session, McKesson (MCK) closed at $695.17, marking a +1.86% move from the previous day.
In the most recent trading session, McKesson (MCK) closed at $694.70, indicating a +0.27% shift from the previous trading day.
Over the last three years, diversification has fallen out of fashion. When investors can make 20% or higher returns in technology stocks and even more from the Magnificent 7, the idea of investing in low-growth dividend stocks loses some appeal.
McKesson (MCK) closed the most recent trading day at $679.33, moving +1.13% from the previous trading session.
McKesson acquires 80% ownership in PRISM Vision Holdings, diversifying its business into the high-growth area of ophthalmology. The deal is to be accretive this year.
MCK IS UP OVER 14 POINTS AFTER THE TRADEPULSE ALERT
An aging U.S. population is increasing the demand for medication, and this company delivers.